PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved a variation application from Pfizer (Malaysia) Sdn Bhd in relation to updating the shelf life of Covid-19 Comirnaty Concentrate for Dispersion for Injection vaccine.
The Health Ministry Pharmacy Services senior director Norhaliza A Halim said the new shelf life is from 15 months to 18 months for vaccine vials stored at -90°C to -60°C.
She said the extension of the shelf life involved vaccines MAL21016022AZ manufactured by Pfizer Manufacturing Belgium NV and MAL21036039ASZ by BioNTech Manufacturing GmbH, Germany. "The extension of the product's shelf life has been given based on the latest stability data submitted by the manufacturer.
"The approval of this shelf life extension is retrospective, meaning that this approval also applies to all stocks including all stocks that have been received before this shelf life extension variation is approved,” she said in a statement on Friday . Norhaliza said the ministry was always committed to ensuring that all pharmaceutical products including the COVID-19 vaccine supplied in Malaysia have been assessed in terms of quality, safety and effectiveness by the NPRA.- Bernama
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
KKM pantau rapi isu keselamatan produk Comirnaty Bivalent Covid-19Ia susulan dakwaan kononnya vaksin jenis Comirnaty Bivalent Covid-19 boleh mencetuskan strok iskemik (iskemia otak).
Read more »
Covid-19: No cases of stroke reported in clinical studies of Comirnaty bivalent vaccineKUALA LUMPUR: No cases of stroke were reported in clinic studies for the Comirnaty bivalent Covid-19 vaccine, according to data submitted by product registration holder Pfizer Sdn Bhd to the National Pharmaceutical Regulatory Agency (NPRA).
Read more »
Tiada laporan kes strok dalam kajian vaksin Comirnaty Bivalent, kata KP kesihatan | The Malaysian InsightNPRA akan terus pantau keselamatan semua vaksin Covid digunakan di Malaysia, kata Dr Noor Hisham.
Read more »
NPRA monitoring data after early signal links bivalent shots to strokeHealth DG notes only one US system found the early warning signal.
Read more »